Drug intelligence / Profile preview

chondroitin sulfate disaccharide

Development stage
Preclinical
Lead developer
University of South Carolina
Modality
Small Molecules
Administration
Oral
01

Overview

Chondroitin sulfate disaccharide is a low-molecular-weight carbohydrate derivative of chondroitin sulfate, currently being investigated for its immunomodulatory properties in the treatment of autoimmune diseases such as multiple sclerosis. Its mechanism of action involves the induction of specific microRNAs, notably miR-29b and miR-199b, which subsequently down-regulate the expression of the cell-surface glycoprotein CD44 on lymphocytes. This down-regulation inhibits lymphocyte proliferation and migration into the central nervous system. Additionally, the disaccharide modulates cytokine profiles, typically reducing pro-inflammatory IL-17 and enhancing anti-inflammatory IL-4 levels, thereby suppressing the development and progression of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis.

Other names
chondroitin disaccharide
02

Targets

CD44 (CD44 antigen)miR-29b (MicroRNA 29b)

Beyond the preview

Go deeper on chondroitin sulfate disaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chondroitin sulfate disaccharide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call